Bluetongue
Proceedings of the Third International Symposium
Part II
(N. James MacLachlan & James E. Pearson, eds) |
|
| |
|
| Contents
|
|
| |
|
| List of abbreviations |
409 |
| |
|
| |
|
| Bluetongue virus and disease |
|
| |
|
H. Huismans, V. van Staden, W.C. Fick,
M. van Niekerk & T.L. Meiring
A comparison of different orbivirus proteins that could affect virulence and pathogenesis |
|
| |
|
P.P.C. Mertens, J. Diprose, S. Maan, K.P. Singh,
H. Attoui & A. Samuel
Bluetongue virus replication, molecular and structural biology |
426-437 |
| |
|
L.I. Pritchard, P.W. Daniels, L.F. Melville, P.D. Kirkland, S.J. Johnson, R. Lunt & B.T. Eaton
Genetic diversity of bluetongue viruses in Australasia |
438-445 |
| |
|
K.R. Bonneau & N.J. MacLachlan
Genetic diversification of field strains of bluetongue virus |
446-447 |
| |
|
P.D. Kirkland & R.A. Hawkes
A comparison of laboratory and 'wild' strains of bluetongue virus - is there any difference and does it matter? |
448-455 |
| |
|
H.-H. Takamatsu, P.S. Mellor & P.P.C. Mertens
A potential overwintering mechanism for bluetongue virus – recent findings |
456-461 |
| |
|
N.J. MacLachlan
Bluetongue: pathogenesis and duration of viraemia |
462-467 |
| |
|
S.V. Nikolakaki, K. Nomikou, O. Mangana-Vougiouka,
M. Papanastassopoulou, M. Koumbati & O. Papadopoulos
S10 segment sequence analysis of some Greek bluetongue virus strains |
468-472 |
| |
|
G. Savini, A.C. Potgieter, F. Monaco, O. Mangana-Vougiouka, K. Nomikou, H. Yadin & V. Caporale
VP2 gene sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean Basin during the 1998-2002 outbreak |
473-478 |
| |
|
K.P. Singh, S. Maan, A.R. Samuel,
S. Rao, A. Meyer & P.P.C. Mertens
Phylogenetic analysis of bluetongue virus genome segment 6 (encoding VP5) from different serotypes |
|
| |
|
S. Maan, N.S. Maan, A.R. Samuel, R. O’Hara, A.J. Meyer,
S. Rao & P.P.C. Mertens
Completion of the sequence analysis and comparisons of genome segment 2 (encoding outer capsid protein VP2) from representative isolates of the 24 bluetongue virus serotypes |
|
| |
|
S. Maan, A.R. Samuel, N.S. Maan,
H. Attoui, S. Rao &
P.P.C. Mertens
Molecular epidemiology of bluetongue viruses from disease outbreaks in the Mediterranean Basin |
489-496 |
| |
|
P.D. Kirkland, L.F. Melville, N.T. Hunt, C.F. Williams &
R.J. Davis
Excretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus |
497-501 |
| |
|
L.F. Melville, N.T. Hunt, S.S. Davis & R.P. Weir
Bluetongue virus does not persist in naturally infected cattle |
502-507 |
| |
|
J.R. White, V. Boyd, J.K. Brangwyn, C.J. Duch, L.I. Pritchard, L.F. Melville, T.D. St George & B.T. Eaton
Characterisation and monitoring of neutralisation-resistant VP2 phenotypes
in BTV-1 isolates from northern Australia collected over a twenty-year period |
508-512 |
| |
|
D.M. White & J.O. Mecham
Lack of detectable bluetongue virus in skin of seropositive cattle: implications for vertebrate overwintering of bluetongue virus |
513-519 |
| |
|
E.W. Howerth, G.S. Parlavantzas & D.E. Stallknecht
Replication of epizootic haemorrhagic disease and bluetongue viruses in DH82 cells |
520-524 |
| |
|
| |
|
| Diagnostics |
|
| |
|
B.T. Eaton & J.R. White
Developing new orbivirus diagnostic platforms |
525-530 |
| |
|
S. Zientara, E. Bréard & C. Sailleau
Bluetongue diagnosis by reverse transcriptase-polymerase chain reaction |
531-537 |
| |
|
C. Hamblin
Bluetongue virus antigen and antibody detection, and the application of laboratory diagnostic techniques |
538-545 |
| |
|
S. Anthony, S. Maan, A.R. Samuel, P.S. Mellor &
P.P.C. Mertens
Differential diagnosis of bluetongue virus using a reverse transcriptase-polymerase chain reaction for genome segment 7 |
546-551 |
| |
|
S. Maan, N.S. Maan, K.P. Singh, A.R. Samuel &
P.P.C. Mertens
Development of reverse transcriptase-polymerase chain reaction-based assays and sequencing for typing European strains of bluetongue virus and differential diagnosis of field and vaccine strains |
552-561 |
| |
|
L. Velić, R. Velić, T. Bajrović,
B. Dukić & D. Čamo
Bluetongue in Bosnia: comparisons of competitive enzyme-linked immunosorbent assay and standard agar gel immunodiffusion tests |
562-563 |
| |
|
H. Dadhich
Bluetongue: an overview of recent trends in diagnostics |
564-566 |
| |
|
J. Brenner, M. Malkinson & H. Yadin
Application of diagnostic procedures to epidemiological situations with special reference to arboviral infections |
567-571 |
| |
|
P. de Santis, G. Orrù, F. Solinas,
V. Piras, G. Savini & V. Caporale
Molecular differentiation of field and vaccine strains of bluetongue virus serotype 2 using the real-time polymerase chain reaction and fluorescence resonance energy transfer hybridisation probes |
|
| |
|
R. Lelli, M. Di Ventura, M.T. Mercante, M. Tittarelli,
O. Mangana-Vougiouka,
K. Nomikou, A. Conte,
B. Di Emidio†, O. Portanti, G. Giovannucci, B. Bonfini,
M. Zaghini & V. Caporale
Bluetongue laboratory diagnosis: a ring test to evaluate serological results using a competitive ELISA kit |
|
| |
|
B. Djuricić, G. Jermolenko, B. Milosević, S. Radojičić,
Z. Debeljak & A. Tomić
The first bluetongue virus isolation in Yugoslavia |
581-582 |
| |
|
S. Shimizu, I. Toyota, T. Arishima & Y. Goto
Frequency of serological cross-reactions between Ibaraki and bluetongue viruses using the agar gel immunodiffusion test |
583-586 |
| |
|
W.C. Wilson, D.E. Stallknecht & J.O. Mecham
Field-deployable real-time polymerase chain reaction detection of bluetongue and epizootic haemorrhagic disease viral ribonucleic acid |
587-593 |
| |
|
| |
|
| Vaccines |
|
| |
|
P. Roy
Genetically engineered structure-based vaccine for bluetongue disease |
594-600 |
| |
|
C. Patta, A. Giovannini, S. Rolesu, D. Nannini, G. Savini,
P. Calistri, U. Santucci & V. Caporale
Bluetongue vaccination in Europe: the Italian experience |
601-610 |
| |
|
G. Gerbier, P. Hendrikx, F. Roger, S. Zientara,
F. Biteau-Coroller, C. Grillet,
T. Baldet & E. Albina
Bluetongue control using vaccines: experience of the Mediterranean islands |
611-615 |
| |
|
B. Dungu, T. Gerdes & T. Smit
The use of vaccination in the control of bluetongue in southern Africa |
616-622 |
| |
|
A. Santi, L. Loli Piccolomini, P. Viappiani, M. Tamba,
R. Calabrese & I. Massirio
Bluetongue control using vaccines: the experience of Emilia Romagna, Italy |
623-626 |
| |
|
G. Savini, F. Monaco, A. Facchinei, C. Pinoni, S. Salucci,
F. Cofini & M. Di Ventura
Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production |
627-630 |
| |
|
G. Savini, F. Monaco, A. Conte, P. Migliaccio,
C. Casaccia, S. Salucci & M. Di Ventura
Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9 |
631-634 |
| |
|
C. Stelletta, V. Cuteri, L. Bonizzi, A. Frangipane di Regalbono, F. Orsi, L. Nisoli, D. Lulla & M. Morgante
Effect of levamisole administration on bluetongue vaccination in sheep |
635-639 |
| |
|
B. Di Emidio†, P. Nicolussi, C. Patta, G.F. Ronchi,
F. Monaco, G. Savini, A. Ciarelli & V. Caporale
Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2 |
640-644 |
| |
|
G. Savini, M. Tittarelli, B. Bonfini, M. Zaghini,
M. Di Ventura & F. Monaco
Serological response in cattle and sheep following infection or vaccination with bluetongue virus |
|
| |
|
A. Giovannini, A. Conte, G. Panichi, P. Calistri, M. Dessì,
F. Foddis, A. Schintu & V. Caporale
Effects of vaccination against bluetongue on milk production and quality in cattle vaccinated with live-attenuated monovalent type 2 vaccine |
|
| |
|
G. Lucifora, P. Rossi, P. Calistri & A. Giovannini
Effects of bivalent bluetongue serotypes 2 and 9 vaccine on reproductive performance of cattle: a case study in Calabria, Italy |
|
| |
|
F. Monaco, N. De Luca, P. Spina, D.Morelli, I. Liberatore,
R. Citarella, A. Conte & G. Savini
Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9 |
657-660 |
| |
|
F. Monaco, N. De Luca, D. Morelli, M. Pisciella,
S. Palmarini, M. Di Giandomenico & G. Savini
Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production |
661-663 |
| |
|
G. Savini, F. Monaco, R. Citarella, G. Calzetta, G. Panichi,
A. Ruiu & V. Caporale
Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows |
664-667 |
| |
|
G. Savini, F. Monaco, P. Calistri, G. Panichi, A. Ruiu,
A. Leone & V. Caporale
Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2 |
668-670 |
| |
|
F. Monaco, B. Bonfini, M. Zaghini, D. Antonucci, A. Pini &
G. Savini
Vaccination of cattle using modified-live monovalent vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy |
671-675 |
| |
|
| |
|
| Control and trade |
|
| |
|
A. Schudel, D. Wilson & J.E. Pearson
Office International des Épizooties international standards for bluetongue |
676-681 |
| |
|
J. Février
European Union policy for the control and eradication of bluetongue |
682 |
| |
|
W.R. DeHaven, J.A. del Valle Molina & B. Evans
Bluetongue virus and trade issues: a North American perspective |
683-687 |
| |
|
G.R. Oliver
Bluetongue trade issues – an Australian perspective |
688-690 |
| |
|
M.E. Mogajane
Trade implications of bluetongue in Africa |
691-692 |
| |
|
A.R. Cameron
The impact of current and proposed changes to general guidelines on bluetongue surveillance of the Office International des Épizooties |
693-696 |
| |
|
A. Giovannini, A. Conte, P. Calistri,
C. Di Francesco &
V. Caporale
Risk analysis on the introduction into free territories of vaccinated animals from restricted zones |
697-702 |
| |
|
G. Filipponi, R. Lelli, U. Santucci, C. Carteny, P. Calistri,
C. Weiss & V. Caporale
Implementation of a new contingency plan for bluetongue disease in Italy |
703-706 |
| |
|
D. Nannini, P. Calistri, A. Giovannini,
M. Di Ventura, M.A. Cafiero, G. Ferrari, U. Santucci & V. Caporale
Health management of large transhumant animal populations and risk of bluetongue spread to disease-free areas |
|
| |
|
| |
|
| Conclusions
of Working Groups |
|
| |
|
| Group 1 Monitoring and surveillance |
713 |
| |
|
| Group 2 Vectors |
715 |
| |
|
| Group 3 Diagnostics |
718 |
| |
|
| Group 4 Vaccines and vaccination |
720 |
| |
|
| Group 5 Impact of interventional strategies on virus spread, disease and regulation |
721 |
| |
|
| Group 6 Control and trade |
722 |
| |
|
| |
|
| Overview -
B.I. Osburn |
724 |
| |
|
| Index
of authors and co-authors |
727 |
| |
|
| |
|
Part I
Vet Ital 40 (3): October-December 2004 |
40 (3) |
| |
|
| Publicity
leaflet |
|
